Primary Analysis of the SYMPATICO trial in Mantle Cell Lymphoma
Focusing on mantle cell lymphoma, Lori A. Leslie, MD, reviews the primary analysis of the SYMPATICO trial investigating ibrutinib-venetoclax combination therapy.
Source: onclive.com
Sympatico Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sympatico Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sympatico Study Today - Breaking & Trending Today